T1	Intervention 168 210	single and repeat oral dose study of YM17E
T2	Intervention 447 648	YM17E was administered after a meal to two groups of subjects (each containing six subjects taking the drug and three taking placebo) receiving 3, 60 and 300 mg or 15, 60 and 450 mg YM17E, respectively
